Harold H. Shlevin, Director at GALECTIN THERAPEUTICS INC (GALT), bought 6,500 shares at $1.16 ($8K) on 2024-12-30, disclosed to the SEC on 2024-12-31.
Open-market purchase of $8k GALT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | SELL | 2018-06-14 | $565K | — | Filing → |